London, UK and Ann Arbor, MI – NextGen Group Plc (AIM: NGG), an AIM listed company providing biomarker discovery and testing services has completed the establishment of its new diagnostics subsidiary company (NextGen Sciences Dx Inc.). The board of NextGen believes that the creation of the diagnostics business as a separate corporate entity is an […]
REDWOOD CITY, Calif., Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, announced today that it has commenced an action against Sequenom, Inc. and its wholly-owned subsidiary, Sequenom Center for Molecular Medicine, LLC (“Sequenom CMM”), in federal court. The action, filed in the Northern District of California, seeks a declaratory judgment that […]
ANN ARBOR, Mich. and AMSTERDAM, Rubicon Genomics, Inc., a company developing and commercializing sample-specific pre-analytical processes to improve the capabilities and performance of DNA and RNA analytical platforms, today announced a clinical supply agreement with molecular diagnostics firm Agendia for its TransPLEX® whole genome RNA amplification technology. Agendia will incorporate Rubicon’s TransPLEX kits into the […]
PLEASANTON, Calif., Roche and Life Technologies Corporation (LTC) announced today that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications. Under these two agreements, Roche has granted LTC an in vitro diagnostics product license to all of Roche’s patents for real-time PCR (polymerase chain reaction) as […]
SEATTLE – Integrated Diagnostics (InDi®), an emerging leader in molecular diagnostics, today announced that the company has made substantial progress in its diagnostic programs, triggering a $10 million third tranche of its Series A financing. The company will use the funds to complete clinical development of its in vitro proteomic-based diagnostics programs and prepare for […]
NEW YORK, NY, Enzo Biochem, Inc. (NYSE:ENZ) today announced that the New York State Department of Health has approved Enzo Clinical Labs’ use of the ColonSentry™ test for providing an assessment of a patient’s risk of having colorectal cancer. The ColonSentry™ test was originally developed by GeneNews (TSX: GEN) and requires only a small blood […]
Austin, Texas, Asuragen, Inc. announced today the immediate availability of the miRInform® Pancreas Test in its CAP-accredited CLIA Laboratory. miRInform® Pancreas was developed to aid physicians in the diagnosis and management of pancreatic ductal adenocarcinoma (PDAC) when cytology is inconclusive. The test evaluates expression levels of seven miRNAs in Fine Needle Aspirate (FNA) specimens of […]
SANTA CLARA, Calif., Affymetrix, Inc. today announced that its GeneChip® System 3000Dx v.2 (GCS 3000Dx v.2) has been approved by China’s State Food and Drug Administration (SFDA) for in vitro diagnostic use. The GCS 3000Dx v.2 is the first microarray instrument system to be granted SFDA registration for array-based diagnostics for enabling personalized medicine. China […]
MOUNTAIN VIEW, Calif., DNAnexus, a DNA data management and analysis platform, today announced agreements with leading institutions – Geisinger Health System (GHS) and the University of California, San Francisco (UCSF) – to develop clinically relevant workflows to provide new insights into the use of DNA sequencing in medicine. As part of these relationships, key laboratories […]
Franklin Lakes, NJ, BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today the expansion of its microbiology portfolio to include new automated instrumentation technologies that will enable the Company to offer innovative total lab automation solutions to hospitals and laboratories worldwide. The acquisition of KIESTRA Lab Automation BV, a Netherlands-based company that […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
